The last ten years have seen a notable increase in balloon pulmonary angioplasty safety.

Published Date: 23 Apr 2023

The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.

Read Full News

Latest News

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Exploring First-Line Immunotherapy-Based Combinations in Advanced NSCLC

Exploring First-Line Immunotherapy-Based Combinations in Advanced NSCLC

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Exploring First-Line Immunotherapy-Based Combinations in Advanced NSCLC

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

News All Time

Alzheimer's Risk May Be Influenced by Flu Shots

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia

Here's How Many Doctors and Nurses Are Getting Flu or COVID Shots

Nurses in particular do not seem to be fans of the COVID-19 vaccine

Trump: 'It Was Me as a Doctor'; Lululemon PFAS Probe; Dick Vitale's Fifth Cancer Dx

Health news and commentary gathered by MedPage Today staff

Quiz Time: How Are Flu Shots and Alzheimer's Linked?

You passed medical training, now see if you can pass our weekly quiz

Doc Detained by Border Patrol; Lady Gaga Sick, Cancels Show; Sexy Chocolate Recall

Health news and commentary gathered by MedPage Today staff

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer

Zoldonrasib ideal for further evaluation in KRAS G12D-mutant disease, expert says

Amoxicillin Alone Holds Up for Acute Sinusitis

Observational study supports efficacy, safety compared with amoxicillin-clavulanate

Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line

Zongertinib in phase I trial showed sustained efficacy in aggressive disease

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Findings of TB DNA will require larger studies to confirm clinical relevance, says researcher

Congresswoman Tied to COVID Fraud Resigns; DOD Ends Flu Vax Mandate; USPSTF Overhaul

Health news and commentary gathered by MedPage Today staff

If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

In a post-pandemic landscape, the drug didn't top usual care at stopping hospitalization, death

Bronchial Casts: An Unusual Complication of Wildfire Smoke Inhalation

Case is a "graphic demonstration" of emergent, severe impacts of forest fires for everyday people

Why Is a Healthy 22-Year-Old Male Suddenly Fainting and Short of Breath?

Careful questioning about patient's recent behaviors gave vital clue

Portable Tuberculosis Diagnostic Tool Matched Traditional Tests' Results

The MiniDock MTB could expand access to molecular testing in peripheral health centers

Symptoms, Radiologic Findings Point to COVID-19 -- but It's Not

Clue from a previous diagnosis of another disease?

Why Is Patient's Pneumonia Not Responding to Treatment?

Identifying one key measurement made all the difference

Recommended News For You

For treatment, the majority of cancer patients choose complementary therapies.

The Cherenkov color image shows the possibility of improving the quality of radiation therapy.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

FDA Expands Approval of Osimertinib in Lung Cancer

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

Recommended Articles For You

Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence 

The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care 

ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy 

What is Mullerian and How Does it Affect Your Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Providing essential cancer care to rural communities

2.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

3.

Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment

4.

Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.

5.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

1.

Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence

2.

Demystifying Lymphocytes: Everything You Need to Know 

3.

A New Hope: Exploring the Benefits of Exenteration for Cancer Patients

4.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

5.

What You Need to Know About the Early Warning Signs of Colon Cancer 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot